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Background: Health in All Policies (HiAP) is a form of intersectoral action that aims to include the promotion of
health in government initiatives across sectors. To date, there has been little study of economic considerations
within the implementation of HiAP.
Methods: As part of an ongoing program of research on the implementation of HiAP around the world, we examined
how economic considerations influence the implementation of HiAP. By economic considerations we mean the cost
and financial gain (or loss) of implementing a HiAP process or structure within government, or the cost and financial
gain (or loss) of the policies that emerge from such a HiAP process or structure. We examined three jurisdictions:
Sweden, Quebec and South Australia. Semi-structured telephone interviews were conducted with 12 to 14 key
informants in each jurisdiction. Two investigators separately coded transcripts to identify relevant statements.
Results: Initial readings of transcripts led to the development of a coding framework for statements related to
economic considerations. First, economic evaluations of HiAP are viewed as important for prompting HiAP and
many forms of economic evaluation were considered. However, economic evaluations were often absent, informal, or
incomplete. Second, funding for HiAP initiatives is important, but is less important than a high-level commitment to
intersectoral collaboration. Furthermore, having multiple sources of funding of HiAP can be beneficial, if it increases
participation across government, but can also be disadvantageous, if it exposes underlying tensions. Third, HiAP can
also highlight the challenge of achieving both economic and social objectives.
Conclusions: Our results are useful for elaborating propositions for use in realist multiple explanatory case studies. First,
we propose that economic considerations are currently used primarily as a method by health sectors to promote and
legitimize HiAP to non-health sectors with the goal of securing resources for HiAP. Second, allocating resources and
making funding decisions regarding HiAP are inherently political acts that reflect tensions within government sectors.
This study contributes important insights into how intersectoral action works, how economic evaluations of HiAP
might be structured, and how economic considerations can be used to both promote HiAP and to present barriers
to implementation.
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Several high-profile reports over the past three decades
have argued that intersectoral action is required to
address the social determinants of health [1-4]. Inter-
nationally, governments have taken notice that a com-
prehensive commitment to health means looking beyond
the traditional health care sector. Health in All Policies
(HiAP) is a form of such action that seeks to integrate
health considerations in the development, implementa-
tion and evaluation of policies through conjoint leader-
ship within and across sectors [5,6].
Policymakers have described HiAP implementation as
challenging given the need to engage and collaborate
with diverse health and non-health sectors [7,8]. Eco-
nomic considerations may be particularly important for
several reasons. By economic considerations we mean
the cost and financial gain (or loss) of implementing a
HiAP process or structure within government, or the
cost and financial gain (or loss) of the policies that
emerge from such a HiAP process or structure.
Policy makers with limited time horizons might prioritize
short-term economic goals (such as cost control) over
long-term health outcomes [9,10]. Yet HiAP interventions
may be promoted as a means of controlling long-term
health care costs by preventing disease [7]. In addition,
intersectoral action is promoted as a way to address over-
lap and redundancy in times of fiscal constraint [11]. Fi-
nally, funding practices, such as integrated budgets and
joint accounting, are key for implementing HiAP [8,12].
Policymakers engaged in developing or implementing
HiAP initiatives would benefit from a detailed understand-
ing of how economic considerations have been addressed
in jurisdictions that have used HiAP.
While a number of descriptions of HiAP implementa-
tion have been published, there is little research on how
and why such initiatives succeeded or failed in different
settings [13]. This study presents a thematic analysis of
how economic considerations affected the implementa-
tion of HiAP in three jurisdictions. Our objectives were
to identify key economic issues and to explore the
consistency in how these issues were relevant to imple-
mentation in different contexts. By implementation of
HiAP processes and the subsequent policies that emerge,
we mean actions to carry out governmental decisions as
specified through legislation, formal strategy or mandate
[14]. We restricted our focus to such actions and did not
include implementation related to policy generation or
changing governance structures.
Methods
We conducted an international systematic scoping
review in 2011 that identified established, formal HiAP
initiatives [15]. HiAP was defined as multisectoral initia-
tives toward healthy public policy making, coordinatedprimarily by government, where sectors collaborate by de-
veloping policies, programs and projects that include in-
terventions addressing upstream social determinants of
health [4,14]. HiAP encompasses both public health inter-
ventions and non-health interventions that have health
benefits. HiAP objectives have included improving health
(and possibly other benefits), establishing the cost-
effectiveness of HiAP programs and reducing heath and
social inequities. Herein, we focus on questions related to
efficiency and equity that arise when implementing HiAP.
From 43 jurisdictions where some form of intersec-
toral action for health equity had been implemented, we
identified 16 that had extensively adopted HiAP policies.
Our research team constructed a set of criteria for case
selection. We focused on cases where there was a clear
mandate for HiAP that could be identified. We included
cases that had been initiated within the previous 10
years to ensure that informants could recall past events
with sufficient detail, and excluded cases that had been
initiated only within the last two years, as they may not
yet be viable. We required multiple sources of data on
each case, so excluded those with few sources in the grey
or peer-reviewed literature. As the focus of this program
of research has been implementation, we further excluded
cases that had not yet reached the maintenance or evalu-
ation stage. Finally, we chose cases that had similar GDP,
similar level of government where HiAP was initiated and
implemented and similar policy process. We have com-
pleted three explanatory case studies to date – Sweden,
Quebec and South Austrialia – that form the basis of this
report (Table 1). All cases are high-income countries but
represent a variety in terms of the type of welfare state.
Ethics approval was obtained from the St. Michael’s
Hospital Research Ethics Board.
Key informant recruitment and data collection
We identified potential key informants in each juris-
diction based on a review of grey and peer-reviewed
literature. Potential informants were contacted by email
or telephone and asked to rate their familiarity with
implementation of their specific initiative; those who
said they were familiar to very familiar were eligible
for an interview. Additional informants were identi-
fied through snowball sampling. We conducted semi-
structured telephone interviews in the official language
of each jurisdiction using a detailed interview guide.
Informed consent was obtained from participants and
only adults were interviewed. We intervied 12 to 14 per-
sons in each jurisdiction. Further details are available
elsewhere[15].
Data analysis
We used a qualitative iterative approach to develop a
thematic analysis of economic considerations [16]. English
Table 1 The contextual factors of HiAP implementation in Sweden, Quebec and South Australia
Contextual factors Sweden Quebec South Australia
Welfare state regime High-income High-income High-income
High in labour market egalitarianism Low in labour market egalitarianism (Canada) Low in labour market egalitarianism (Australia)
Mandate type & year Legislated bill, 2003 Legislated in Public Health Act, 2002 Strategy, 2008
Mandate description Minister of Health with directors-general of
“concerned agencies” guides national,
regional and municipal level intersectoral
health coordination in regards to the health
policy. There was a change in 2008 initiated
by the Moderate Party (centre-right) where
the focus shifted to elderly, children and
young people with emphasis on lifestyle
changes.
All prospective policies that may impact population
health must pass through a health impact assessment
administered by the Ministry of Health and Social Services.
Health lens analyses are used to help government
sectors meet targets laid out in the South Australia
Strategic Plan (2004). There was a change in 2011
initiated by the Australian Labor Party (left-leaning)
with an amendment to the Public Health Act to
include a provision that the Minister of Health may
provide advice or develop procedures to ensure
enhancement of health.
Level of implementation Country, county, municipal Province State, municipal
Financing HiAP At the national level, there are no financing
mechanisms to directly fund sectors to
participate in HiAP and to conduct Health
Impact Assessments (HIA) but some examples
of coordinated budgeting/policy-oriented
funding to encourage action on specific
objectives. The Swedish National Institute
of Public Health provides in-kind support
to sectors at all levels of government to
integrate health considerations in policymaking,
including the use of HIA tools and hosting
cross-sectoral meetings. Sectors may pool
budgets when they collaborate. At the
municipal level HiAP work is financed
by the various sectors and from various
state/public donors with supported by public
health coordinator.
At the provincial level, there are no financing mechanisms
to directly fund sectors to participate in HiAP or to carry
out HIA. Ministries are expected to provide in-kind support
to allow employees to participate in the inter-ministerial
committee. The Direction Générale de Santé Publique funds
research to support the development of knowledge and
expertise in using HIA tools and the Institut National de
Santé Publique du Québec provides in-kind support to
sectors at all levels government to use HIA tools.
At the state level, there are no financing mechanisms
to directly fund sectors to participate in HiAP. Individual
projects rely on joint funding from partner agencies.
Foundation of HiAP in South Australia acknowledges
that many of the most pressing health problems of
the population require long-term policy and budgetary
commitment, including innovative budgetary approaches.
Dedicated funding for global aspects of HiAP initiative
provided by South Australia Health, and for dedicated
staff in a Health in All Policies Unit provided by Health
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(South Australia) of each interview were read by two
members of the investigative team (AP, AM). These in-
vestigators independently identified statements relevant
to economic considerations and then jointly developed
a coding framework based on the health literature and
classified statements using this framework. The coding
framework included three categories: (1) economic eval-
uations of HiAP [5,17,18]; (2) resources and financing
for HiAP [8,19]; and (3) structural economic consider-
ations (such as the state of the national and inter-
national economy and local economic policies) [20-22].
Finally, the entire investigative team reviewed the state-
ments to identify themes. Themes were identified and
refined through iterative readings and discussions until
no further themes were identified. Important contextual
factors were noted. The investigators represent a range
of disciplines (medicine, law, health policy, social epi-
demiology, health economics, public health), thereby
enhancing methodological rigor [23].Results
Across the three categories, we identified six themes, as
described below.Economic evaluations of HiAP
Economic arguments are important for promoting HiAP
We found general agreement regarding the importance
of promoting HiAP based on economic evaluations,
meaning the analysis of alternative courses of action in
terms of both costs and outcomes [24]. As noted by
one informant, “we need to develop more knowledge
on these issues in order to meet the demand about
which policies are most cost-efficient”. Such evalua-
tions were perceived to facilitate buy-in for HiAP
across government sectors. As one informant noted, “it
is central today to be able to show that policies are
worth it from an economic point of view.” Several in-
formants noted that economic evaluations of HiAP
were seen as particularly important for controlling
rising health care costs; others argued that HiAP is
“efficient” because it represents investing in interven-
tions in order to prevent poor health or social out-
comes, which were framed as having a net negative
cost to society in the long-term. Thus, HiAP appeared
to be seen as providing a means for policymakers to
assess the positive and negative health consequences of
options. Such consequences could be monetized and
the costs or gains could be included in the analysis of
options. Yet informants recognized that many govern-
ments undervalue preventive services, which may only
be considered after the daily “more urgent issues agenda”
has been addressed.Many forms of economic evaluation were considered
The specific form of economic evaluation was often not
specified but many informants emphasized that HiAP
should demonstrate that money will be saved. Others
suggested evaluating how much poor population health
costs society or focused on the affordability of the HiAP
intervention by stressing the direct cost (e.g. staff time,
organizing meetings across sectors, etc.) of implement-
ing HiAP. Finally, some suggested that it is important to
show that HiAP leads to a “return on investment”, that
it was economically efficient, or that it represents the
best use of resources compared to alternative courses of
action.
Economic evaluations of HiAP are often absent, informal or
incomplete
The evidence base for economic evaluation was often ab-
sent or unclear. Informants described limited experience
with economic evaluation, pointing to several administra-
tive and methodological difficulties. For example, the time
horizons over which effects could be observed (typically
years) are often too long for governments with more im-
mediate concerns. Similarly, the short-term time horizon
for implementation costs is often very different from the
long-term time horizon for health and social benefits and
any attendant savings.
Another important challenge for HiAP is measuring
benefits. While health economists have developed
methods for incorporating health-related quality-of-
life effects, HiAP benefits might include non-health
effects that may be difficult to measure and challen-
ging to include on a common scale with health effects.
Informants also noted that it could be difficult to at-
tribute changes to HiAP interventions alone given
concurrent policy changes.
Resources and financing for HiAP
The financing of HiAP initiatives varied across cases
(Table 1).
Funding for HiAP initiatives is important, but is less
important than a high-level commitment to intersectoral
collaboration
Informants consistently noted that “sometimes, some
small amount of additional money is needed [such as]
for the organization of intersectoral conferences, but
mainly, HiAP does not require more money” and that
“some extra money is sometimes useful to get some
speed in some projects”. Typically, the financing of HiAP
occurred through existing budgets. An informant sug-
gested that, rather than devoting specific resources to
the implementation of HiAP, “we should be better at
what we are already doing, by thinking strategically
about health and sustainable development”. Some
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cing might lead to dis-engagement when funding stops
and, therefore, short-lived action.
One informant noted that intersectoral policy work
often requires “an extra bit” of effort that can represent
considerable uncounted costs. This “in-kind support …
is probably the most important source of funding.” That
is, “if you put a dollar value and add up all the hours
and all the [HiAP] informants who are doing this as an
extra bit of their work, you get massive amounts”. As
noted by an informant in Sweden, the key objective for
those working in small municipalities on HiAP imple-
mentation is knowledge sharing rather than gain from
new financial resources.
However, an absolute lack of financial resources is a
barrier to HiAP implementation. Because financing has
symbolic significance, sectors may perceive that a lack of
HiAP funding means signals that the initiative is a lower
priority. Informants stated that “health is a ‘soft’ issue,
when resources are missing, its significance declines”
and that “with less resources, people get very much
focused on their own mission and they are less open to
collaborate intersectorally”. Despite the sense that HiAP
could lead to efficiencies and cost-saving in the long-
term, another informant suggested that HiAP may not
be implemented at all if budgets are too constrained in
the short-term.
Co-financing of HiAP is seen as being both beneficial and
detrimental
Multiple sources of funding, such as pooled budgets
across sectors, may support HiAP implementation. As
noted by an informant from South Australia, “it’s truly a
partnership approach … we’re working together along-
side each other to solve and to investigate the problem
and to come up with a policy solution.” In Sweden, the
central government initiates HiAP projects and ongoing
financing and implementation is the responsibility of
municipalities. Thus, the two levels of government were
reported as “contributing to the financing of the project”
and this helped establish both as “co-owners”.
However, several negative aspects of co-financing were
identified. It is difficult to assemble resources from dif-
ferent actors that receive financing from different levels
of government (municipal, county or regional). An in-
formant from South Australia noted that successfully
navigating through different bureaucracies requires a
“skill set around engaging with other departments and/
or communities.” The need for multiple funding sources
can expose underlying tensions between levels of gov-
ernment. For example, key informants reported that mu-
nicipal governments may bear the burden of HiAP
implementation but receive only part of the resources
necessary from the central government.Structural economic considerations for HiAP
The existing tension within government ministries between
addressing economic and social/health objectives is
highlighted by HiAP initiatives
Some informants identified difficulties in engaging pol-
icymakers outside of the health sector in HiAP initia-
tives. For ministries whose primary goal is economic
development, “taking into consideration the health im-
pacts counts for nothing”. An informant noted that
when a policy has an impact on “business outcomes …
it creates incredible tension … between economic
deliverables … and social deliverables”. For example,
between increasing employment or economic product-
ive and improving health outcomes. However, policy
goals that are framed as having both economic and
health or social benefits facilitate buy-in for HiAP. For
example, a sustainable development strategy linked to
HiAP was highlighted by several informants at the mu-
nicipal level in Sweden as leading to a high degree of
buy-in across sectors. A key scientific report describing
the connection between multiple determinants of
health and sustainable development, and the integra-
tion of public health targets into sectoral plans to
achieve sustainable development, attracted a wide
range of politicians to participate in the initiative. In
addition, inclusion of these targets in the city’s imple-
mentation budget signaled that these objectives were
political priorities that “automatically” led to the par-
ticipation of all sectors.
Discussion
We used thematic analysis to evaluate views regarding
economic considerations among stakeholders interested
in and participating in implementing HiAP using case
studies from Sweden, Quebec, and South Australia. In-
formants consistently stated that economic consider-
ations are important for promoting HiAP to non-health
sectors within governments. This finding itself is not
surprising. As others have noted when discussing HiAP,
“Health partners must recognize the importance of
non-health goals to non-health partners and develop
an economic case for action” [8]. However, there was
considerable heterogeneity and lack of clarity in how
economic considerations were conceptualized. Infor-
mants appeared to confuse affordability (i.e. this inter-
vention is possible with our existing resources) with
efficiency (i.e. this intervention is a good use of re-
sources, given alternatives).
Economic evaluations of HiAP may provide informa-
tion that better allows for a more complete cost assess-
ment of different policy and program options. However,
few robust economic evaluations of HiAP interventions
have been completed to date and there are considerable
conceptual and logistical challenges to such evaluations
Pinto et al. BMC Public Health  (2015) 15:171 Page 6 of 9[25-28]. Methodological concerns include questions about
the appropriate time horizon for an analysis, the chal-
lenges in measuring non-health benefits, and difficulties in
comparing benefits on a common scale [9,10]. Costs and
outcomes may accrue to different sectors of government,
and capturing this data requires extensive cross-sectoral
information systems. Existing evaluations on the impact
and effectiveness of intersectoral action for health equity
also lack descriptions of contextual factors, such as the
roles and responsibilities of sectors and intersectoral
relationships, and how these were related to observed
outcomes of the interventions [29]. The appropriate
perspective for the evaluation also needs to be defined.
A health system perspective, by definition, would be
too narrow for HiAP. A societal perspective, that
counts all costs and effects regardless of who pays or
benefits, is often favored by economists but might be
too broad for governmental decision makers. HiAP
economic evaluations will need to develop methods
that appropriately reflect a distinct “whole of govern-
ment” perspective that incorporates relevant trade-offs
related to costs and outcomes between sectors.
Many informants felt that demonstrating that HiAP is
cost saving would provide strong evidence in favor of
sustained implementation. Nevertheless, no informants
provided evidence that downstream savings offset the
cost of HiAP interventions; instead, such arguments
seem to be based on intuitive comparisons of relatively
inexpensive implementation costs to the high costs of
downstream health and social consequences. Of note,
preventative health services are similarly believed to be
cost-saving but very few result in net negative costs [30].
Other informants argued that HiAP is worthwhile be-
cause the societal cost of continued inaction to address
important social determinants, such as poverty, is high.
While such arguments might have validity, quantifying
the effects of addressing such determinants is beyond
the scope of most economic evaluations, which are
typically used to guide resource allocation decisions.
From this perspective, the most rigorous approach
would compare the marginal net cost of a HiAP inter-
vention, relative to a comparator, and the marginal net
effects. A few informants framed economic consider-
ations in such terms, using words such as “efficiency” or
“cost-effectiveness”.
HiAP is sometimes promoted as a means to reduce
health sector costs or as a mechanism for increasing
public health funding [7,31]. However, focusing too
strongly on the economic outcomes of HiAP might
detract from the potential health and social impacts [32].
Furthermore, several informants noted that views of
HiAP can change according to economic conditions.
Economic downturns and austerity budgets can represent
real threats to the implementation of HiAP processes –both because HiAP might be seen as an expendable extra
and because sectors become very protective of their own
funds and give less priority to intersectoral collaboration
[33]. There was a strong sentiment amongst informants
that implementing HiAP without dedicated funding left
HiAP programs vulnerable to budget cuts.
Few studies have evaluated the costs of implementing
HiAP [5]. We note that our informants did not discuss
the importance of estimating the cost of scaling up ini-
tiatives found to be good value for money. One inform-
ant noted that the opportunity cost of HiAP can be
considerable if implementation diverts resources from
other activities and no extra funding is allocated [34].
Although integrated budgets and joint accounting have
been identified as methods to promote the implementa-
tion of HiAP [12,19], our results are more equivocal.
Multiple sources of funding might be advantageous to
generate broader buy-in across levels of government but
could be disadvantageous if underlying tensions within
government are exposed and exacerbated. Other ana-
lyses of HiAP implementation have suggested that lead-
ership, either political or bureaucratic, and fostering
personal interactions across networks, is essential to en-
gage diverse stakeholders and manage such tensions [8].
Joint budgeting can be vulnerable to spending cuts as
departments often start by reducing or eliminating
contribution to intersectoral initiatives [35]. Delegated
financing to support HiAP processes are similarly quite
susceptible to economic downturns, necessitating cre-
ative interventions to keep the public and policymakers
supportive of intersectoral action to improve health [8].
Having a specific budget for HiAP can also be a chal-
lenge if it reduces the motivation of non-health sector
actors to take responsibility for the health impact of
their policies [34].
Our study has some limitations. We used a definition
of HiAP that focused on health inequities. We recognize
that this may have limited the scope of our study and
might limit the generalizability of our findings to HiAP
interventions where equity is not a primary policy ob-
jective. We focused only on three jurisdictions and on
implementations that occurred in a particular period.
Our coding framework was structured around three
categories that developed from initial readings. How-
ever, themes could have categorized in a number of
different ways. We might have identified additional
views regarding implementation and barriers to HiAP
in other contexts, beyond the three case studies exam-
ined. Particularly important contextual factors might
include country, economic conditions, and govern-
mental jurisdictional responsibilities. We also did not
explore some macroeconomic issues that might be im-
portant for considering HiAP, including tax policies,
public and private health insurance systems, and social
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mention specific examples or specific policies where
economic considerations had particularly been import-
ant as they implemented HiAP in their jurisdiction.
This lack of concrete examples limits our findings to
mostly abstract conceptualizations of how such consid-
erations shape HiAP implementation. Future research
on the economic considerations HiAP could explore
its application to specific policies, such as those regu-
lating the alcohol and food industry, or economic
development and extractive industries.
Ultimately, decisions about which HiAP policies get
funded and the amount of resources theyreceive are
political decisions that reflect power relations both within
and without government, as well as stakeholders’ values
and ideological perspectives [8]. As called for in the 2013
Helsinki Statement on Health in All Policies, there is a need
for “conflict of interest measures that include effective safe-
guards to protect policies from distortion by commercial
and vested interests and influence” [36] While we focused
specifically on economic issues related to the implementa-
tion of HiAP interventions, future research should focus on
the political economy of implementing HiAP policies.
Our results are useful for elaborating propositions for
use in realist multiple explanatory case studies, a new
method for understanding how macrosocial health equity
interventions are implemented. This approach seeks to
explain causal effects within each case by developing a
specific understanding of phenomena in relation to the
context while refining explanatory theory applicable to the
collection of cases by testing main and rival propositions
(similar to hypotheses). These propositions are a form of
middle-range theory, which fall short of unified theory
intending to “explain all observed uniformities of social
behavior, social organization and social change” but that
can help explain certain occurrences. Propositions are
typically developed on the basis of existing theory, past
experience and previous evaluations or research studies,
including through the observation of semi-predictable,
re-occurring patterns identified in data [37].
Accordingly, we suggest two propositions related to
economic considerations and HiAP. We stress that these
propositions are explanatory rather than normative; that
is, they seek to explain how decisions are actually made
rather than to propose how they should be made. First,
we propose that economic considerations are currently
used primarily as a method by health sectors to promote
and legitimize HiAP to non-health sectors with the goal of
securing resources for HiAP. More specifically, our results
suggest that individuals responsible for implementing
HiAP are primarily interested in arguments that are
focused on seemingly common-sense findings (‘reducing
poverty must save money’) rather than on formal analyses,
whether simple (such as analyses of implementation costsor budget impact) or complex (such as cost-effectiveness
analyses within or across sectors). This proposition di-
verges from an idealized version of economic evaluation
where economic evaluations are used as the primary basis
for resource allocation decisions. However, as discussed
above, methods to conduct economic evaluations of HiAP
initiatives are not well elaborated. Moreover, it is possible
that economic arguments could detract from health con-
cerns, perhaps for reasons related to this proposition.
Taken together, these considerations suggest that eco-
nomic evidence is valued for its functional role rather than
as intrinsically reflecting the worth of HiAP or for guiding
resource allocation decisions.
Our second proposition is that allocating resources and
making funding decisions regarding HiAP are inherently
political acts that reflect tensions within government sec-
tors. More specifically, governments’ political agendas, the
relative power of individual ministries or departments and
the state of the economy each influenced whether HiAP
was a priority for research allocation and how much fund-
ing a specific implementation received. Informants were
considerably concerned about whether HiAP funding was
secure, whether HiAP resources reflected opportunity
costs, and whether HiAP implementation was threatened
during times of economic austerity.
HiAP interventions are vulnerable for several reasons.
First, HiAP is seen to come from the health sector, which
already consumes a large amount of resources. Other
sectors might be unenthusiastic about earmarking more
funds for health, and evidence shows that even in the case
of strong, government wide commitment to HiAP, eco-
nomic and trade policy considerations can dampen system-
atic efforts to implement HiAP [38]. As Second, HiAP
interventions are sometimes seen as discretionary additions
to established systems. Third, cross-jurisdictional funding
and responsibility might make HiAP programs particularly
vulnerable if they do not have a strong champion [6,39].
Conclusions
Our propositions contribute to our understanding of
HiAP, which currently lacks a strong theoretical base.
Our study highlights the need for further work to exam-
ine how the successful implementation of HiAP relates
to a number of factors in the policy process, one aspect
being economic considerations.
Our themes and propositions about the role and use
of economic arguments and evaluations in support of
HiAP should be examined in additional cases that ex-
plore the politics of the budgetary process in-depth, as
has been done in other areas [40], and is currently missing
from much of the research on intersectoral governance
and HiAP. Finally, the specific role of such evidence in
ensuring the long-term sustainability of HiAP is also a
topic for further inquiry.
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